1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
date : 6/28/2013
Japan will experience an aging society by 2035 as one in three people in Japan will be over the age of 65. Japan will be the first country in human history to experience such a phenomenon, hence, it is Japan’s duty to ask questions; “How to Age and How to Die” and “The Ideal Ways of End of Life Care .” The aging issue has been known as a forbidden topic that cannot be discussed in the public but it is time to change. In the light of this, this consecutive seminar will aim to hold a discussion that allows young professionals from economic, medical, academic, media, legislative and administrative sectors to suggest action plans.
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program:
1. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community (Speaker:Yoshinori Hiroi (Professor at Chiba University, School of Law)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program:
1. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community (Speaker:Yoshinori Hiroi (Professor at Chiba University, School of Law)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
Exhibition date:2013-07-02
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
-
2026-03-03
[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)
-
2026-03-23
[Registration Open] Application for the Health Policy Academy the 15th Session (Session Starts July 2026)
-
2026-04-01
[Registration Open] (Webinar) The 143rd HGPI Seminar “20 Years Since the Enactment of the Cancer Control Act: Reflecting on the Past and Envisioning the Next 20 Years” (April 28, 2026)



